WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
NCT07216651
·
clinicaltrials.gov ↗
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity & Overweight
Sponsor
Closed Loop Medicine